Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
0(0%)
Results Posted
78%(7 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
11
92%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
N/ANon-phased studies
11(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(9)
Terminated(1)
Other(2)

Detailed Status

Completed9
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
90.0%
Most Advanced
N/A

Trials by Phase

N/A11 (100.0%)

Trials by Status

completed975%
unknown217%
terminated18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
12